product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Mouse anti Human Inhibin Alpha
catalog :
MCA951ST
quantity :
0.2 ml
price :
144 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
R1
reactivity :
human, mouse
application :
western blot, immunohistochemistry, immunohistochemistry - paraffin section
more info or order :
Bio-Rad product webpage
citations: 10
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry - paraffin section; mouse; 1:250; loading ...; fig 7d
Meinsohn M, Saatcioglu H, Wei L, Li Y, Horn H, Chauvin M, et al. Single-cell sequencing reveals suppressive transcriptional programs regulated by MIS/AMH in neonatal ovaries. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  • immunohistochemistry - paraffin section; mouse; fig s3
Saatcioglu H, Cuevas I, Castrillon D. Control of Oocyte Reawakening by Kit. PLoS Genet. 2016;12:e1006215 pubmed publisher
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; tbl 2
Liang L, Huang H, Dadhania V, Zhang J, Zhang M, Liu J. Renal cell carcinoma metastatic to the ovary or fallopian tube: a clinicopathological study of 9 cases. Hum Pathol. 2016;51:96-102 pubmed publisher
  • immunohistochemistry; human; 1:50; tbl 2
Liang L, Olar A, Niu N, Jiang Y, Cheng W, Bian X, et al. Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases. Am J Surg Pathol. 2016;40:847-56 pubmed publisher
  • immunohistochemistry - paraffin section; mouse; fig 3
Kadariya Y, Cheung M, Xu J, Pei J, Sementino E, Menges C, et al. Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations. Cancer Res. 2016;76:2836-44 pubmed publisher
  • immunohistochemistry - paraffin section; human; 1:20
Kasem K, Lam A. Adrenal oncocytic phaeochromocytoma with putative adverse histologic features: a unique case report and review of the literature. Endocr Pathol. 2014;25:416-21 pubmed publisher
  • immunohistochemistry; human
Marino F, Risbridger G, Gold E. The inhibin/activin signalling pathway in human gonadal and adrenal cancers. Mol Hum Reprod. 2014;20:1223-37 pubmed publisher
  • western blot; human; 1:80
Zhang K, Shi J, Lin F. Immunohistochemical evaluation of inhibin-alpha in non-small-cell lung carcinomas--a pitfall in diagnosing metastatic pulmonary carcinomas. Ann Clin Lab Sci. 2012;42:118-22 pubmed
Sanz Pamplona R, Aragues R, Driouch K, Martín B, Oliva B, Gil M, et al. Expression of endoplasmic reticulum stress proteins is a candidate marker of brain metastasis in both ErbB-2+ and ErbB-2- primary breast tumors. Am J Pathol. 2011;179:564-79 pubmed publisher
Irizarry Rovira A, Lennox A, Ramos Vara J. Granular cell tumor in the testis of a rabbit: cytologic, histologic, immunohistochemical, and electron microscopic characterization. Vet Pathol. 2008;45:73-7 pubmed publisher
image
image 1 :
Bio-Rad MCA951ST image 1
Human testis stained with Mouse anti Human Inhibin alpha antibody, clone R1 ( MCA951ST ), showing Sertoli cells, Leydig cells and spermatogonia. Formalin fixed paraffin processed tissue
product information
Entity Type :
Monoclonal Antibody
Entity Category :
Antibodies
ProductCode :
MCA951ST
Description :
Mouse anti Human Inhibin Alpha
Specificity :
Inhibin Alpha
TargetSpecies :
Human
Host :
Mouse
Format :
S/N
Isotypes :
IgG2a
Applications :
P,C
ApplicationTypes :
Immunohistology - Paraffin,Immunohistology - Frozen
Cross Reactivities :
Bovine,Sheep
Clone :
R1
Quantity :
0.2 ml
Quantity Value :
0.2
Quantity Type :
ml
GO Accessions :
GO:0001501,GO:0001541,GO:0004871,GO:0005125,GO:0005179,GO:0006917,GO:0007050,GO:0007166,GO:0007267,GO:0007399,GO:0008083,GO:0009605,GO:0046881,GO:0046882,GO:0030218,GO:0034673,GO:0042127,GO:0042326,GO:0042541,GO:0043512,GO:0045077,GO:0045578,GO:0045650
GOTerms :
skeletal system development,ovarian follicle development,signal transducer activity,cytokine activity,hormone activity,induction of apoptosis,cell cycle arrest,cell surface receptor linked signaling pathway,cell-cell signaling,nervous system development,growth factor activity,response to external stimulus,positive regulation of follicle-stimulating hormone secretion,negative regulation of follicle-stimulating hormone secretion,erythrocyte differentiation,inhibin-betaglycan-ActRII complex,regulation of cell proliferation,negative regulation of phosphorylation,hemoglobin biosynthetic process,inhibin A complex,negative regulation of interferon-gamma biosynthetic process,negative regulation of B cell differentiation,negative regulation of macrophage differentiation
Uniprot Accessions :
P05111
Gene :
INHA
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3623
Entity Formats :
S/N
UNSPSC :
41116161
Product Form :
Tissue Culture Supernatant - liquid
PriceGBP :
102
PriceEUR :
184
PriceUSD :
144 USD
PriceCHF :
200
PriceSEK :
2006
PriceNOK :
2016
PriceDKK :
1372
NotForSaleInCountries :
AU
more info or order :
Bio-Rad product webpage
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.